Independent Financial Information Made Easy
The development of Artificial Intelligence (AI) is modifying the way investments are evaluated. We programmed an artificial intelligence (A.I.) to summarize the whole internet. Whether you’re trying to make money investing online, making financial decisions or just getting informed about Wall Street, this page is a way to get informed without reading hundred of pages. Our stock market summary graphs are produced using machine learning, an unbiased view to capture what internet is saying. Usually, the AI reads several hundred pages and summarize it to a short text and several charts.
Open: 274.86 Close: 283.6 Change: 8.74
This document will help you to evaluate Amgen without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Amgen are: Amgen, complete, Horizon, Therapeutics, acquisition, plc, announce, and the …
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's products include Enbrel, Prolia, Xgeva, Otezla, Aranesp, and Repatha..
Amgen completed its acquisition of Horizon Therapeutics plc for $116.50 per share in cash. FDA panel will not give its blessing to approval of Amgens cancer drug, Lumakras.
Amgen Inc. to be replaced Home Investing Quotes Stocks United States AMGN. Amgen completed its acquisition of Horizon Therapeutics plc for $116.50 per share in cash, representing a transaction equity value of approximately $27.8 billion. Amgen to present at Morgan Stanley Global Healthcare Conference at 8:50 a.m. Amgen and Horizon Therapeutics plc (NASDAQ:HZNP) announced the entry into a consent order agreement with the Federal Trade Commission that resolves the pending FTC administrative lawsuit. Amgen acquires horizon therapeutics for $27.8bn (£22.76bn) The latest acquisition will bolster the inflammation portfolio of Amgen. Tepezza could be a core driver for Amgen, an analyst says. The Amgen Biotech Experience program expands to reach more than 180,000 additional students over next two years. This latest expansion is made possible by additional funding of $12.4 million. FDA panel will not give its blessing to approval of Amgen Inc.s cancer drug, Lumakras. The Arbs of October Score Big on Amgen-Horizon: Bloomberg Deals. Amgen was the best-performing stock in both the Dow Jones Industrial Average and Nasdaq 100 in the third quarter. Amgen will present at the Merrill Lynch Global Bank of America Healthcare Conference. Repatha is an injectable prescription medicine used: in adults with cardiovascular disease to reduce the risk of heart attack, stroke, and certain types of heart surgery. For Repatha patients, Amgen SupportPlus offers additional support. Amgen can obtain a copy of this Authorization or cancel this Authorization at any time by calling Amgen at 1-844-REPATHA (737-2842) or by writing to PO Box 1366, Morristown NJ, 07962. I understand that by signing this form, I authorize my health care providers or others who might hold my health information. By opting into the Amgen ® SupportPlus program, you consent to receive a maximum of 6 messages per month from mobile short code 72328. By using the Service and accepting these terms, you also agree to Amgens. Amgen completes acquisition of Horizon Therapeutics plc. Amgen completed its acquisition of horizon Therapeutic plc for $116.50 per share in cash. Amgen completed takeover of Irish-based rare disease specialists Horizon Therapeutics. Amgen won out in a three-way tussle with Sanofi and Johnson & Johnson when it last December announced what was the biggest pharmaceutical deal of the year. Scam Advisory: Special Advisory: Please be cautious of scam recruitment offers claiming to be from Amgen. Amgen has completed its acquisition of Horizon Therapeutics. Amgen is excited to announce the first and only targeted treatment specifically designed for patients with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer. Amgen announces @US_FDA approval of the first biologic for #severeasthma. Amgen CEO Bob Bradway discusses our recent decision to end two clinical trials. Listen to the full podcast here: https:// bit.ly/3c9uedX $AMGN. 50-60% of the water is reused at Amgen Manufacturing Limited, our largest biomanufacturing facility located in Juncos, Puerto Rico. Amgen completed its purchase of Horizon Therapeutics for an approximate value of $27.8 billion. Amgen revealed in a company press release that it has officially finished its purchase.
"Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; and Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization. It also markets Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. It has collaboration agreements with Novartis Pharma AG; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; Eli Lilly and Company; Datos Health; and Verastem, Inc. to evaluate VS-6766 in combination with lumakrastm (Sotorasib) in patients with KRAS G12C-mutant non-small cell lung cancer. It has an agreement with Kyowa Kirin Co., Ltd. to jointly develop and commercialize KHK4083, a Phase 3-ready anti-OX40 fully human monoclonal antibody for the treatment of atopic dermatitis and other autoimmune diseases; and research and development collaboration with Neumora Therapeutics, Inc. and Plexium, Inc. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California."
How much time have you spent trying to decide whether investing in Amgen? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Amgen are: Amgen, complete, Horizon, Therapeutics, acquisition, plc, announce, and the most common words in the summary are: amgen, news, patient, horizon, stock, job, best, . One of the sentences in the summary was: FDA panel will not give its blessing to approval of Amgens cancer drug, Lumakras.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #amgen #news #patient #horizon #stock #job #best.
Read more →Open: 276.84 Close: 273.17 Change: -3.67
Read more →Open: 272.81 Close: 273.75 Change: 0.94
Read more →Open: 279.1 Close: 278.49 Change: -0.61
Read more →Open: 283.85 Close: 283.51 Change: -0.34
Read more →Open: 287.71 Close: 283.7 Change: -4.01
Read more →Open: 323.64 Close: 323.19 Change: -0.45
Read more →Open: 323.64 Close: 323.11 Change: -0.53
Read more →Open: 310.57 Close: 311.77 Change: 1.2
Read more →Open: 304.73 Close: 307.81 Change: 3.08
Read more →Open: 305.24 Close: 306.51 Change: 1.27
Read more →Open: 308.02 Close: 307.61 Change: -0.41
Read more →Open: 280.0 Close: 284.16 Change: 4.16
Read more →Open: 277.83 Close: 275.18 Change: -2.65
Read more →Open: 276.27 Close: 275.45 Change: -0.82
Read more →Open: 271.17 Close: 269.12 Change: -2.05
Read more →Open: 269.96 Close: 272.45 Change: 2.49
Read more →Open: 267.71 Close: 269.64 Change: 1.93
Read more →Open: 264.79 Close: 264.59 Change: -0.2
Read more →Open: 269.41 Close: 265.39 Change: -4.02
Read more →Open: 268.52 Close: 269.86 Change: 1.34
Read more →Open: 265.0 Close: 263.19 Change: -1.81
Read more →Open: 282.09 Close: 280.6 Change: -1.49
Read more →Open: 263.15 Close: 267.47 Change: 4.32
Read more →Open: 262.1 Close: 261.46 Change: -0.64
Read more →Open: 272.07 Close: 269.86 Change: -2.21
Read more →Open: 255.75 Close: 259.43 Change: 3.68
Read more →Open: 256.71 Close: 254.01 Change: -2.7
Read more →Open: 258.68 Close: 256.71 Change: -1.97
Read more →Open: 256.96 Close: 256.04 Change: -0.92
Read more →Open: 266.33 Close: 265.02 Change: -1.31
Read more →Open: 261.54 Close: 262.06 Change: 0.52
Read more →Open: 237.91 Close: 243.28 Change: 5.37
Read more →Open: 233.77 Close: 234.82 Change: 1.05
Read more →Open: 227.84 Close: 227.43 Change: -0.41
Read more →Open: 221.21 Close: 225.01 Change: 3.8
Read more →Open: 229.87 Close: 227.11 Change: -2.76
Read more →Open: 227.31 Close: 229.18 Change: 1.87
Read more →Open: 219.34 Close: 218.76 Change: -0.58
Read more →Open: 219.67 Close: 222.1 Change: 2.43
Read more →Open: 215.96 Close: 216.93 Change: 0.97
Read more →Open: 224.21 Close: 224.44 Change: 0.23
Read more →Open: 224.85 Close: 223.99 Change: -0.86
Read more →Open: 224.44 Close: 223.42 Change: -1.02
Read more →Open: 224.75 Close: 222.61 Change: -2.14
Read more →Open: 234.89 Close: 234.11 Change: -0.78
Read more →Open: 236.82 Close: 239.74 Change: 2.92
Read more →Open: 276.85 Close: 277.93 Change: 1.08
Read more →Open: 276.3 Close: 272.86 Change: -3.44
Read more →Open: 284.84 Close: 283.46 Change: -1.38
Read more →Open: 287.71 Close: 283.7 Change: -4.01
Read more →Open: 287.88 Close: 285.88 Change: -2.01
Read more →Open: 323.64 Close: 323.19 Change: -0.45
Read more →Open: 314.5 Close: 324.56 Change: 10.06
Read more →Open: 304.73 Close: 307.81 Change: 3.08
Read more →Open: 304.73 Close: 307.81 Change: 3.08
Read more →Open: 305.24 Close: 306.51 Change: 1.27
Read more →Open: 284.5 Close: 286.53 Change: 2.03
Read more →Open: 280.0 Close: 284.16 Change: 4.16
Read more →Open: 276.27 Close: 276.17 Change: -0.1
Read more →Open: 271.17 Close: 269.12 Change: -2.05
Read more →Open: 271.87 Close: 270.87 Change: -1.0
Read more →Open: 269.96 Close: 272.45 Change: 2.49
Read more →Open: 264.74 Close: 266.6 Change: 1.86
Read more →Open: 265.34 Close: 262.82 Change: -2.52
Read more →Open: 269.41 Close: 265.39 Change: -4.02
Read more →Open: 263.3 Close: 265.12 Change: 1.83
Read more →Open: 268.95 Close: 261.57 Change: -7.38
Read more →Open: 274.86 Close: 283.6 Change: 8.74
Read more →Open: 263.15 Close: 266.09 Change: 2.94
Read more →Open: 267.67 Close: 267.7 Change: 0.03
Read more →Open: 265.0 Close: 271.46 Change: 6.46
Read more →Open: 255.75 Close: 259.43 Change: 3.68
Read more →Open: 258.68 Close: 256.71 Change: -1.97
Read more →Open: 258.68 Close: 256.71 Change: -1.97
Read more →Open: 266.33 Close: 265.02 Change: -1.31
Read more →Open: 261.7 Close: 262.51 Change: 0.81
Read more →Open: 257.52 Close: 258.83 Change: 1.32
Read more →Open: 236.48 Close: 234.15 Change: -2.33
Read more →Open: 227.79 Close: 232.57 Change: 4.78
Read more →Open: 225.85 Close: 227.07 Change: 1.22
Read more →Open: 224.16 Close: 222.61 Change: -1.55
Read more →Open: 227.31 Close: 229.04 Change: 1.73
Read more →Open: 229.03 Close: 228.77 Change: -0.26
Read more →Open: 223.08 Close: 221.22 Change: -1.86
Read more →Open: 213.75 Close: 218.07 Change: 4.32
Read more →Open: 220.1 Close: 217.46 Change: -2.64
Read more →Open: 224.21 Close: 225.29 Change: 1.08
Read more →Open: 224.44 Close: 223.42 Change: -1.02
Read more →Open: 224.44 Close: 224.06 Change: -0.38
Read more →Open: 226.02 Close: 225.02 Change: -1.0
Read more →Open: 238.08 Close: 235.97 Change: -2.11
Read more →Open: 236.82 Close: 239.74 Change: 2.92
Read more →